These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19086767)

  • 21. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
    Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA; Olabisi OA; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.
    Howell LL; Negus SS
    Adv Pharmacol; 2014; 69():129-76. PubMed ID: 24484977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine treatment for cocaine abuse: the dopamine depletion hypothesis.
    Dackis CA; Gold MS; Davies RK; Sweeney DR
    Int J Psychiatry Med; 1985-1986; 15(2):125-35. PubMed ID: 3902694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-ethyltryptamines as dual dopamine-serotonin releasers.
    Blough BE; Landavazo A; Partilla JS; Decker AM; Page KM; Baumann MH; Rothman RB
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4754-4758. PubMed ID: 25193229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction.
    Nonkes LJ; van Bussel IP; Verheij MM; Homberg JR
    Behav Pharmacol; 2011 Dec; 22(8):723-38. PubMed ID: 22015806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological approaches to cocaine addiction.
    Dackis CA; Gold MS
    J Subst Abuse Treat; 1985; 2(3):139-45. PubMed ID: 3912517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior.
    Broderick PA; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1037-54. PubMed ID: 14499322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour.
    Carey RJ; Huston JP; Müller CP
    Prog Brain Res; 2008; 172():347-60. PubMed ID: 18772041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys.
    Berro LF; Perez Diaz M; Maltbie E; Howell LL
    Psychopharmacology (Berl); 2017 Sep; 234(17):2607-2617. PubMed ID: 28584928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction.
    Rothman RB; Partilla JS; Dersch CM; Carroll FI; Rice KC; Baumann MH
    Ann N Y Acad Sci; 2000 Sep; 914():71-81. PubMed ID: 11085310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical and behavioral evidence supporting (+)-AJ 76 as a potential pharmacotherapy for cocaine abuse.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(10-12):1307-24. PubMed ID: 9928899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Norepinephrine and stimulant addiction.
    Sofuoglu M; Sewell RA
    Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders.
    Newman AH; Ku T; Jordan CJ; Bonifazi A; Xi ZX
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():609-628. PubMed ID: 33411583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S; De Deurwaerdère P; Porras G; Spampinato U
    Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.